These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30061672)

  • 1. Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption.
    Guan J; Shen Q; Zhang Z; Jiang Z; Yang Y; Lou M; Qian J; Lu W; Zhan C
    Nat Commun; 2018 Jul; 9(1):2982. PubMed ID: 30061672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short Peptide-Mediated Brain-Targeted Drug Delivery with Enhanced Immunocompatibility.
    Guan J; Jiang Z; Wang M; Liu Y; Liu J; Yang Y; Ding T; Lu W; Gao C; Qian J; Zhan C
    Mol Pharm; 2019 Feb; 16(2):907-913. PubMed ID: 30666875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A stabilized peptide ligand for multifunctional glioma targeted drug delivery.
    Ying M; Shen Q; Zhan C; Wei X; Gao J; Xie C; Yao B; Lu W
    J Control Release; 2016 Dec; 243():86-98. PubMed ID: 27693752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein.
    Mima Y; Hashimoto Y; Shimizu T; Kiwada H; Ishida T
    Mol Pharm; 2015 Jul; 12(7):2429-35. PubMed ID: 26070445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-ligand α
    Levine RM; Kokkoli E
    J Control Release; 2017 Apr; 251():24-36. PubMed ID: 28215671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
    Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
    ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
    J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
    McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
    Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of surface displayed targeting ligand GE11 on liposome distribution and extravasation in tumor.
    Tang H; Chen X; Rui M; Sun W; Chen J; Peng J; Xu Y
    Mol Pharm; 2014 Oct; 11(10):3242-50. PubMed ID: 25181533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of synthetic peptide-modified liposomes with LDL receptor targeting capacity and improved anticancer activity.
    Liu M; Li W; Larregieu CA; Cheng M; Yan B; Chu T; Li H; Mao SJ
    Mol Pharm; 2014 Jul; 11(7):2305-12. PubMed ID: 24830852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A photo-responsive peptide- and asparagine-glycine-arginine (NGR) peptide-mediated liposomal delivery system.
    Xie X; Yang Y; Yang Y; Zhang H; Li Y; Mei X
    Drug Deliv; 2016 Sep; 23(7):2445-2456. PubMed ID: 25693640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand peptide-grafted PEGylated liposomes using HER2 targeted peptide-lipid derivatives for targeted delivery in breast cancer cells: The effect of serine-glycine repeated peptides as a spacer.
    Suga T; Fuchigami Y; Hagimori M; Kawakami S
    Int J Pharm; 2017 Apr; 521(1-2):361-364. PubMed ID: 28237886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption.
    Yamamoto S; Sakurai Y; Harashima H
    Int J Pharm; 2018 Jan; 536(1):42-49. PubMed ID: 29126905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
    Abu Lila AS; Uehara Y; Ishida T; Kiwada H
    J Pharm Sci; 2014 Feb; 103(2):557-66. PubMed ID: 24347396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidic self-assembly of a combinatorial library of single- and dual-ligand liposomes for in vitro and in vivo tumor targeting.
    Ran R; Wang H; Liu Y; Hui Y; Sun Q; Seth A; Wibowo D; Chen D; Zhao CX
    Eur J Pharm Biopharm; 2018 Sep; 130():1-10. PubMed ID: 29908938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.
    Sun J; Jiang L; Lin Y; Gerhard EM; Jiang X; Li L; Yang J; Gu Z
    Int J Nanomedicine; 2017; 12():1517-1537. PubMed ID: 28280323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.